bupropion has been researched along with dihydro-beta-erythroidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caldarone, BJ; Eaton, JB; Kozikowski, AP; Lukas, RJ; Yu, LF; Zhang, HK | 1 |
| AlSharari, S; Bagdas, D; Campbell, VC; Carroll, FI; Damaj, MI; Muldoon, PP; Roni, MA | 1 |
1 review(s) available for bupropion and dihydro-beta-erythroidine
| Article | Year |
|---|---|
Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors.
Topics: Alkaloids; Antidepressive Agents; Azetidines; Azocines; Depression; Humans; Ligands; Molecular Targeted Therapy; Nicotinic Agonists; Nicotinic Antagonists; Quinolizines; Receptors, Nicotinic | 2014 |
1 other study(ies) available for bupropion and dihydro-beta-erythroidine
| Article | Year |
|---|---|
Blockade of nicotinic acetylcholine receptor enhances the responsiveness to bupropion in the mouse forced swim test.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Bupropion; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Immobility Response, Tonic; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Protein Subunits; Psychomotor Performance; Receptors, Nicotinic; Swimming | 2019 |